Technology

Brad Pitt Asks Astronaut: Who was Better? Clooney or Me?
AP Fact Check: Trump Team Distortions on Fuel Economy Rules
NASA Manager Casts Doubt on 2024 Moon Landing by Astronauts

Top Story

AP Fact Check: Trump Team Distortions on Fuel Economy Rules

Brad Pitt Asks Astronaut: Who was Better? Clooney or Me?

By Michael Biesecker Tom Krisher |
President Donald Trump and his team are distorting the facts in explaining the administration's decision to stop California from setting its own emission standards for cars an...

Senate Tech Critic to Facebook CEO: Sell WhatsApp, Instagram

Senate Tech Critic to Facebook CEO: Sell WhatsApp, Instagram

By Marcy Gordon | Sep 20
Rather than moving users' personal data from properties such as WhatsApp and Instagram to the core Facebook platform, the company should put a wall around the services or, better yet, sell them off, a conservative lawmaker said he told Zuckerberg.

AP Fact Check: Trump Team Distortions on Fuel Economy Rules

AP Fact Check: Trump Team Distortions on Fuel Economy Rules

By Michael Biesecker Tom Krisher | Sep 20
President Donald Trump and his team are distorting the facts in explaining the administration's decision to stop California from setting its own emission standards for cars and trucks.

AP-NORC Poll: Americans Somewhat Confident in Climate Fight

AP-NORC Poll: Americans Somewhat Confident in Climate Fight

By Seth Borenstein and Emily Swanson | Sep 20
Most Americans are at least somewhat confident that the world will step up in its fight against global warming — but there are limits to their optimism.

Walgreens, Google Affiliate to Launch Drone Delivery Test

Walgreens, Google Affiliate to Launch Drone Delivery Test

By Tom Murphy | Sep 20
Walgreens and a Google affiliate are testing drone deliveries that can put drugstore products on customer doorsteps minutes after being ordered.

Will Combo Pill Catch On in U.S. to Prevent Heart Attacks?

Will Combo Pill Catch On in U.S. to Prevent Heart Attacks?

By Carla K. Johnson | Sep 20
A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat conditions leading to heart attacks and strokes.